Cargando…
The Enrichment of Survivin in Exosomes from Breast Cancer Cells Treated with Paclitaxel Promotes Cell Survival and Chemoresistance
The generation and release of membrane-enclosed packets from cancer cells, called extracellular vesicles (EVs), play important roles in propagating transformed phenotypes, including promoting cell survival. EVs mediate their effects by transferring their contents, which include specific proteins and...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5187509/ https://www.ncbi.nlm.nih.gov/pubmed/27941677 http://dx.doi.org/10.3390/cancers8120111 |
_version_ | 1782486855422312448 |
---|---|
author | Kreger, Bridget T. Johansen, Eric R. Cerione, Richard A. Antonyak, Marc A. |
author_facet | Kreger, Bridget T. Johansen, Eric R. Cerione, Richard A. Antonyak, Marc A. |
author_sort | Kreger, Bridget T. |
collection | PubMed |
description | The generation and release of membrane-enclosed packets from cancer cells, called extracellular vesicles (EVs), play important roles in propagating transformed phenotypes, including promoting cell survival. EVs mediate their effects by transferring their contents, which include specific proteins and nucleic acids, to target cells. However, how the cargo and function of EVs change in response to different stimuli remains unclear. Here, we discovered that treating highly aggressive MDAMB231 breast cancer cells with paclitaxel (PTX), a chemotherapy that stabilizes microtubules, causes them to generate a specific class of EV, namely exosomes, that are highly enriched with the cell survival protein and cancer marker, Survivin. Treating MDAMB231 cells with a variety of other chemotherapeutic agents, and inhibitors that block cell growth and survival, did not have the same effect as PTX, with the exception of nocodazole, another inhibitor of microtubule dynamics. Exosomes isolated from PTX-treated MDAMB231 cells strongly promoted the survival of serum-starved and PTX-treated fibroblasts and SKBR3 breast cancer cells, an effect that was ablated when Survivin was knocked-down from these vesicles using siRNA. These findings underscore how the enrichment of a specific cargo in exosomes promotes cell survival, as well as can potentially serve as a marker of PTX resistance. |
format | Online Article Text |
id | pubmed-5187509 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-51875092016-12-30 The Enrichment of Survivin in Exosomes from Breast Cancer Cells Treated with Paclitaxel Promotes Cell Survival and Chemoresistance Kreger, Bridget T. Johansen, Eric R. Cerione, Richard A. Antonyak, Marc A. Cancers (Basel) Article The generation and release of membrane-enclosed packets from cancer cells, called extracellular vesicles (EVs), play important roles in propagating transformed phenotypes, including promoting cell survival. EVs mediate their effects by transferring their contents, which include specific proteins and nucleic acids, to target cells. However, how the cargo and function of EVs change in response to different stimuli remains unclear. Here, we discovered that treating highly aggressive MDAMB231 breast cancer cells with paclitaxel (PTX), a chemotherapy that stabilizes microtubules, causes them to generate a specific class of EV, namely exosomes, that are highly enriched with the cell survival protein and cancer marker, Survivin. Treating MDAMB231 cells with a variety of other chemotherapeutic agents, and inhibitors that block cell growth and survival, did not have the same effect as PTX, with the exception of nocodazole, another inhibitor of microtubule dynamics. Exosomes isolated from PTX-treated MDAMB231 cells strongly promoted the survival of serum-starved and PTX-treated fibroblasts and SKBR3 breast cancer cells, an effect that was ablated when Survivin was knocked-down from these vesicles using siRNA. These findings underscore how the enrichment of a specific cargo in exosomes promotes cell survival, as well as can potentially serve as a marker of PTX resistance. MDPI 2016-12-09 /pmc/articles/PMC5187509/ /pubmed/27941677 http://dx.doi.org/10.3390/cancers8120111 Text en © 2016 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Kreger, Bridget T. Johansen, Eric R. Cerione, Richard A. Antonyak, Marc A. The Enrichment of Survivin in Exosomes from Breast Cancer Cells Treated with Paclitaxel Promotes Cell Survival and Chemoresistance |
title | The Enrichment of Survivin in Exosomes from Breast Cancer Cells Treated with Paclitaxel Promotes Cell Survival and Chemoresistance |
title_full | The Enrichment of Survivin in Exosomes from Breast Cancer Cells Treated with Paclitaxel Promotes Cell Survival and Chemoresistance |
title_fullStr | The Enrichment of Survivin in Exosomes from Breast Cancer Cells Treated with Paclitaxel Promotes Cell Survival and Chemoresistance |
title_full_unstemmed | The Enrichment of Survivin in Exosomes from Breast Cancer Cells Treated with Paclitaxel Promotes Cell Survival and Chemoresistance |
title_short | The Enrichment of Survivin in Exosomes from Breast Cancer Cells Treated with Paclitaxel Promotes Cell Survival and Chemoresistance |
title_sort | enrichment of survivin in exosomes from breast cancer cells treated with paclitaxel promotes cell survival and chemoresistance |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5187509/ https://www.ncbi.nlm.nih.gov/pubmed/27941677 http://dx.doi.org/10.3390/cancers8120111 |
work_keys_str_mv | AT kregerbridgett theenrichmentofsurvivininexosomesfrombreastcancercellstreatedwithpaclitaxelpromotescellsurvivalandchemoresistance AT johansenericr theenrichmentofsurvivininexosomesfrombreastcancercellstreatedwithpaclitaxelpromotescellsurvivalandchemoresistance AT cerionericharda theenrichmentofsurvivininexosomesfrombreastcancercellstreatedwithpaclitaxelpromotescellsurvivalandchemoresistance AT antonyakmarca theenrichmentofsurvivininexosomesfrombreastcancercellstreatedwithpaclitaxelpromotescellsurvivalandchemoresistance AT kregerbridgett enrichmentofsurvivininexosomesfrombreastcancercellstreatedwithpaclitaxelpromotescellsurvivalandchemoresistance AT johansenericr enrichmentofsurvivininexosomesfrombreastcancercellstreatedwithpaclitaxelpromotescellsurvivalandchemoresistance AT cerionericharda enrichmentofsurvivininexosomesfrombreastcancercellstreatedwithpaclitaxelpromotescellsurvivalandchemoresistance AT antonyakmarca enrichmentofsurvivininexosomesfrombreastcancercellstreatedwithpaclitaxelpromotescellsurvivalandchemoresistance |